Published in Health Qual Life Outcomes on May 24, 2012
Genetics of psoriasis and pharmacogenetics of biological drugs. Autoimmune Dis (2013) 0.92
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary. Eur J Health Econ (2014) 0.88
Development and psychometric validation of the REFlective evaLuation of psoriasis Efficacy of Treatment and Severity (REFLETS) questionnaire: a common measure of plaque-type psoriasis severity and treatment efficacy for patients and clinicians. J Eur Acad Dermatol Venereol (2014) 0.75
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes (2006) 26.32
Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials (1989) 15.99
Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res (2002) 9.99
A model of equivalence in the cultural adaptation of HRQoL instruments: the universalist approach. Qual Life Res (1998) 4.01
Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol (1997) 2.83
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol (2008) 2.53
Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis. Br J Dermatol (1990) 2.09
A critical look at transition ratings. J Clin Epidemiol (2002) 2.08
Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res (1993) 1.95
Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc (2004) 1.95
Quality of life in patients with psoriasis. Health Qual Life Outcomes (2006) 1.31
Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes (2003) 1.17
Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol (2007) 1.17
Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol (2003) 1.17
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.10
The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol (1995) 1.04
Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol (1999) 1.04
Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol (2006) 1.03
Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol (2010) 0.99
Refinement and reduction of the Impact of Psoriasis Questionnaire: classical test theory vs. Rasch analysis. Br J Dermatol (2006) 0.95
Dimensions of stigmatization in patients with psoriasis in a "Questionnaire on Experience with Skin Complaints'. Dermatology (1996) 0.91
Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ). Int J Dermatol (2006) 0.80
A critical review of Quality-of-Life Scales for Psoriasis. Dermatol Clin (2005) 0.80
[Validation of the Spanish version of the Psoriasis Disability Index questionnaire in assessing the quality of life of patients with moderate-severe psoriasis]. Actas Dermosifiliogr (2005) 0.78
Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied. Transfusion (2007) 1.51
Reinstatement of dapsone following hypersensitivity. Acta Derm Venereol (2003) 1.43
Pseudocystic encapsulation: a late noninflammatory complication of hyaluronic acid filler injections. Dermatol Surg (2013) 1.39
[Sweet's syndrome]. Med Clin (Barc) (2009) 1.39
Occupational dermatitis in a milk industry worker due to Kathon CG. Dermatitis (2004) 1.39
Acute generalized exanthematous pustulosis induced by terbinafine. Eur J Dermatol (2003) 1.38
Multiplex PCR of sonication fluid accurately differentiates between prosthetic joint infection and aseptic failure. J Infect (2012) 1.33
The use of erythromycin and colistin-loaded cement in total knee arthroplasty does not reduce the incidence of infection: a prospective randomized study in 3000 knees. J Bone Joint Surg Am (2013) 1.23
Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol (2004) 1.23
Irritable bowel syndrome subtypes according to bowel habit: revisiting the alternating subtype. Eur J Gastroenterol Hepatol (2003) 1.20
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis. N Engl J Med (2015) 1.20
Hypotrichosis simplex of the scalp is associated with nonsense mutations in CDSN encoding corneodesmosin. Nat Genet (2003) 1.07
Pigmented mammary Paget disease mimicking cutaneous melanoma. Int J Dermatol (2010) 1.06
Deletion of a single β-catenin allele in osteocytes abolishes the bone anabolic response to loading. J Bone Miner Res (2014) 1.02
Periodontal disease severity is related to high levels of C-reactive protein in pre-eclampsia. J Hypertens (2007) 1.00
Sonication versus vortexing of implants for diagnosis of prosthetic joint infection. J Clin Microbiol (2012) 1.00
Acromegaly Quality of Life Questionnaire (AcroQoL). Health Qual Life Outcomes (2004) 1.00
Applications of a New Handheld Reference Point Indentation Instrument Measuring Bone Material Strength. J Med Device (2013) 0.98
Prosthesis failure within 2 years of implantation is highly predictive of infection. Clin Orthop Relat Res (2013) 0.98
Combination of qualitative and quantitative methods for developing a new Health Related Quality of Life measure for patients with anogenital warts. Health Qual Life Outcomes (2005) 0.97
PEDF and the serpins: phylogeny, sequence conservation, and functional domains. J Struct Biol (2005) 0.95
Splitting irritable bowel syndrome: from original Rome to Rome II criteria. Am J Gastroenterol (2004) 0.95
Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subphenotypes. Hum Mol Genet (2012) 0.95
Clinicopathological and immnuohistochemical findings in a series of folliculosebaceous cystic hamartoma. J Cutan Pathol (2008) 0.94
[Generalized eruptive histiocytoma]. Actas Dermosifiliogr (2006) 0.93
T cell responses and viral variability in blood donation candidates with occult hepatitis B infection. J Hepatol (2011) 0.91
Pigmented contact dermatitis due to kojic acid. A paradoxical side effect of a skin lightener. Contact Dermatitis (2010) 0.91
Erythema multiforme photoinduced by statins. Photodermatol Photoimmunol Photomed (2010) 0.90
Annular elastolytic giant cell granuloma associated to late-onset X-linked dominant protoporphyria. Dermatology (2013) 0.90
Morpheaform sarcoidosis. Acta Derm Venereol (2006) 0.90
Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain. Menopause (2012) 0.89
Elastolytic giant cell granuloma: clinic-pathologic review of twenty cases. Dermatol Online J (2013) 0.88
Adult-onset verrucous nevus lipomatosus cutaneous superficialis. Int J Dermatol (2012) 0.87
Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study. Health Qual Life Outcomes (2010) 0.87
Disseminated eruptive clear cell acanthoma with spontaneous regression: further evidence of an inflammatory origin? Am J Dermatopathol (2011) 0.87
Erosive pustular dermatosis of the scalp: a successful treatment with photodynamic therapy. Photodermatol Photoimmunol Photomed (2010) 0.86
Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain. Scand J Infect Dis (2007) 0.86
Impact of upper digestive symptoms in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol (2006) 0.85
Photodynamic therapy in the treatment of extensive Bowen's disease. J Dermatolog Treat (2011) 0.85
Two girls with necrobiosis lipoidica and type I diabetes mellitus with transfollicular elimination in one girl. Pediatr Dermatol (2003) 0.83
Eccrine squamous syringometaplasia secondary to pegylated liposomal doxorubicin. Arch Dermatol (2008) 0.83
Characterization of TGM1 c.984+1G>A mutation identified in a homozygous carrier of lamellar ichthyosis. Int J Dermatol (2012) 0.83
Disseminated superficial porokeratosis with amyloid deposits. Eur J Dermatol (2005) 0.83
Calcium and vitamin D intake by postmenopausal women with osteoporosis in Spain: an observational calcium and vitamin D intake (CaVIT) study. Clin Interv Aging (2013) 0.83
Lichen amyloidosus without itching indicates that it is not secondary to chronic scratching. Acta Derm Venereol (2006) 0.83
Annular elastolytic giant cell granuloma produced on an old burn scar and spreading after a mechanical trauma. Acta Derm Venereol (2003) 0.83
Myasis in uterine prolapse, successful treatment. Am J Obstet Gynecol (2011) 0.83
Coexistence of linear porokeratosis and disseminated superficial actinic porokeratosis: a type 2 segmental manifestation. Acta Derm Venereol (2007) 0.82
Multiple local and recent founder effects of TGM1 in Spanish families. PLoS One (2012) 0.82
Efficacy of topical calcipotriol in the treatment of a giant viral wart. Pediatr Dermatol (2005) 0.82
Correlation study between KSS, WOMAC and SF-36 scores in patients undergoing total knee arthroplasty in a Spanish speaking population. J Arthroplasty (2013) 0.81
Prolonged treatment with rituximab in patients with refractory pemphigus vulgaris. J Dermatolog Treat (2007) 0.81
Calcium and vitamin D intake by postmenopausal women with osteoporosis in France. Curr Med Res Opin (2010) 0.81
Contact dermatitis due to para-phenylenediamine (PPD) on a temporal tattoo with henna. Cross reaction to azoic dyes. Invest Clin (2006) 0.81
Calcified acral angioleiomyoma. J Cutan Pathol (2009) 0.81
Systemic photosensitivity due to Goji berries. Photodermatol Photoimmunol Photomed (2011) 0.80
[Pemphigus vulgaris beginning as the Koebner phenomenon]. Actas Dermosifiliogr (2005) 0.80
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study. Curr Med Res Opin (2005) 0.79
Ulcerated dermatofibroma with osteoclast-like giant cells. J Cutan Pathol (2009) 0.79
Hair-thread tourniquet syndrome: a hidden hazard. Pediatr Dermatol (2012) 0.79
Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis. Int J Dermatol (2004) 0.79
[Porphyria cutanea tarda in a dialyzed female patient]. Actas Dermosifiliogr (2006) 0.79
Prevalence of milia and palatal and gingival cysts in Spanish newborns. Pediatr Dermatol (2011) 0.79
Hyperthermia: from diagnostic and treatments to new discoveries. Recent Pat Biotechnol (2012) 0.79
Contact allergic dermatitis from melamine formaldehyde resins in a patient with a negative patch-test reaction to formaldehyde. Dermatitis (2008) 0.79
Reduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronate. Menopause (2012) 0.79
Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis. Int J Dermatol (2002) 0.79
Reticular erythematous mucinosis (REM) with telangiectasias associated with essential thrombocytosis and lung carcinoma. Eur J Dermatol (2005) 0.78
[Validation of the Spanish version of the Psoriasis Disability Index questionnaire in assessing the quality of life of patients with moderate-severe psoriasis]. Actas Dermosifiliogr (2005) 0.78
Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Int J Dermatol (2007) 0.78
Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases. Cephalalgia (2012) 0.78
Allergic contact dermatitis from EMLA cream in a hemodialyzed patient. Dermatitis (2006) 0.78
Cost-effectiveness analysis of raltegravir in treatment-experienced HIV type 1-infected patients in Spain. AIDS Res Hum Retroviruses (2009) 0.78
Cervicocephalic medial screw migration after intertrochanteric fracture fixation, OTA/AO 31-A2, using intramedullary nail Gamma3: report of 2 cases and literature review. J Orthop Trauma (2013) 0.78
Atypical presentation and dermoscopic evaluation of cutaneous Rosai-Dorfman Disease. Acta Derm Venereol (2009) 0.78
Onychomycosis observed in children over a 20-year period. Mycoses (2010) 0.78
Intensive care unit-related fluconazole use in Spain and Germany: patient characteristics and outcomes of a prospective multicenter longitudinal observational study. Infect Drug Resist (2013) 0.78
Vulvar lichen sclerosus successfully treated with topical tacrolimus. Eur J Obstet Gynecol Reprod Biol (2005) 0.77
Locally advanced and metastatic basal cell carcinoma: molecular pathways, treatment options and new targeted therapies. Expert Rev Anticancer Ther (2014) 0.77
Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration. Dermatol Surg (2004) 0.77
Contact allergy from vitamins in cosmetic products. Dermatitis (2008) 0.77
How genomics has informed our understanding of the pathogenesis of osteoporosis. Genome Med (2009) 0.77
Health-related quality of life in HIV patients switching to twice-daily indinavir/ritonavir regimen or continuing with three-times-daily indinavir-based therapy. Antivir Ther (2004) 0.77
Isotretinoin treatment of acne in a patient with Apert syndrome. Pediatr Dermatol (2003) 0.77
Bayesian regression models for cost-effectiveness analysis. Eur J Health Econ (2005) 0.77
Prospective study of erythema toxicum neonatorum: epidemiology and predisposing factors. Pediatr Dermatol (2011) 0.77
Birt-Hogg-Dubé syndrome in a patient with localized fibrofolliculomas and a novel mutation in the FLCN gene. Int J Dermatol (2011) 0.77
Validation of the Spanish Acne Severity Scale (Escala de Gravedad del Acné Española--EGAE). Eur J Dermatol (2013) 0.76
Allergic contact dermatitis to plants in a Spanish dermatology department: a 7-year review. Contact Dermatitis (2006) 0.76
Allergic contact dermatitis due to transdermal buprenorphine. Contact Dermatitis (2008) 0.76
Hematogenous septic arthritis of the hip in adult patients. Am J Emerg Med (2012) 0.76
Fractures above and below a modular nail for knee arthrodesis. A case report. Knee (2005) 0.76
Imported paracoccidioidomycosis in Spain. Mycoses (2003) 0.76
Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients. Dermatology (2007) 0.76
Letter: Cutaneous mastocytosis with systemic involvement mimicking clinical and dermatoscopically multiple melanocytic nevi. Dermatol Online J (2011) 0.75
Frequency of birthmarks and transient skin lesions in newborns according to maternal factors (diseases, drugs, dietary supplements, and tobacco). Indian J Dermatol Venereol Leprol (2011) 0.75
Ulcerous lesions disclosing cutaneous infection with Fusarium solani. Acta Derm Venereol (2007) 0.75